Kyntra Bio, Inc. KYNB
3.96 USD -0.35 (-8.12%)
At close·Nov 4, 2026, 4:00 PM EST
3.96 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
- YTD
- -54.90%
- 1 year
- -64.00%
Altman Z-Score
-25.90 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
5 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 5
- Debt / Equity 1
- P/E 4
- P/B 1
P/E 0.2×
P/S 5.5×
P/B -1.2×
P/FCF -7.4×
EV/EBITDA 0.2×
EV/Sales -1.9×
FCF Yield -13.6%
Gross Margin 91.4%
Operating Margin -712.7%
Net Margin 2848.6%
ROE -610.7%
ROIC -50.7%
ROA 153.4%
Revenue -78.3%
Operating Income 69.5%
EPS (diluted) 9552.1%
Free Cash Flow 96.5%
Current Ratio 3.4×
Quick Ratio 3.3×
Debt / Equity 0.0×
Net Debt / EBITDA 0.8×
Interest Coverage -5.2×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31